Back to results
US 6,066,317 AGranted
Method of using IL-11 for treating deficiencies in hematopoietic progenitor or stem cells
AssigneeGenetics Institute, Inc.
InventorsYu-Chung Yang, Frances K. Bennett, Stephan R. Paul
Life of this patent
Estimating the term…
Abstract
A novel mammalian cytokine, IL-11, and processes for producing it are disclosed. IL-11 may be used in pharmaceutical preparations for stimulating and/or enhancing cells involved in the immune response and cells involved in the proper functioning of the hematopoietic system.
Claims2
A method for treating deficiencies in hematopoietic progenitor or stem cells, comprising administering a pharmaceutical composition comprising an aqueous solution of IL-11 and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.